Ignite Creation Date:
2025-12-25 @ 4:43 AM
Ignite Modification Date:
2025-12-26 @ 3:44 AM
Study NCT ID:
NCT04989218
Status:
TERMINATED
Last Update Posted:
2024-11-05
First Post:
2021-07-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC)
Sponsor:
University of Alabama at Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-09
First Submit QC Date:
None
Study First Post Date:
2021-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-17
Results First Submit QC Date:
None
Results First Post Date:
2024-11-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-01
Last Update Post Date:
2024-11-05
Last Update Post Date Type:
ACTUAL